Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy

AIMS/HYPOTHESIS: No established blood-based biomarker exists to monitor diabetic sensorimotor polyneuropathy (DSPN) and evaluate treatment response. The neurofilament light chain (NFL), a blood biomarker of neuroaxonal damage in several neurodegenerative diseases, represents a potential biomarker fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Maalmi, Haifa, Strom, Alexander, Petrera, Agnese, Hauck, Stefanie M., Strassburger, Klaus, Kuss, Oliver, Zaharia, Oana-Patricia, Bönhof, Gidon J., Rathmann, Wolfgang, Trenkamp, Sandra, Burkart, Volker, Szendroedi, Julia, Ziegler, Dan, Roden, Michael, Herder, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892145/
https://www.ncbi.nlm.nih.gov/pubmed/36472640
http://dx.doi.org/10.1007/s00125-022-05846-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892145/
https://www.ncbi.nlm.nih.gov/pubmed/36472640
http://dx.doi.org/10.1007/s00125-022-05846-8

Ejemplares similares